Oxford BioMedica (GB:OXB) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Oxford BioMedica PLC has reported a significant change in its shareholder structure, with investment giant BlackRock, Inc. crossing the 5% threshold of combined direct voting rights and financial instruments, now holding a total of 5.01%. The change was triggered by transactions on September 30, 2024, and the company was notified the following day. This development could be of interest to investors monitoring the company’s stock.
For further insights into GB:OXB stock, check out TipRanks’ Stock Analysis page.
